Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation

Autologous stem cell transplantation (ASCT) is the standard of care for multiple myeloma (MM) and relapsing non-Hodgkin’s lymphoma (NHL) patients. Peripheral blood stem cells (PBSC) have become the main source of grafts for ASCT due to several advantages over bone marrow grafts. Poor PBSC mobilizati...

Full description

Bibliographic Details
Main Author: Jan S. Moreb
Format: Article
Language:English
Published: PAGEPress Publications 2011-10-01
Series:Oncology Reviews
Online Access:http://www.oncologyreviews.org/index.php/or/article/view/2

Similar Items